Retuximab as maintenance treatment for follicular lymphoma

Bookmark and Share
Published: 3 Aug 2010
Views: 7395
Prof Gilles Salles, Centre Hospitalier Lyon-Sud, France
Prof Gilles Salles speaks at an EHA 2010 press conference about the PRIMA study which has shown that retuximab 'maintenance' therapy after initial treatment of retuximab plus chemotherapy reduces the risk of follicular lymphoma recurrence by up to 50%. Prof Salles discusses the effects this treatment has on patients, how he expects these results to change clinical practice and his hopes for the development of further effective antibody treatments.